Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Two-State Receptor Model01:29

The Two-State Receptor Model

1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

30
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
30
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

570
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
570
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

931
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
931
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

On-demand growth of semiconductor heterostructures guided by physics-informed machine learning.

Science advances·2026
Same author

Corrigendum to "Electrically enhanced, Nature-Driven microbial attenuation of chromate and dichloromethane in groundwater" [Bioresour. Technol. 459 (2026) 135175].

Bioresource technology·2026
Same author

Electrically enhanced, Nature-Driven microbial attenuation of chromate and dichloromethane in groundwater.

Bioresource technology·2026
Same author

Bladder sarcoma treated with radical cystectomy and adjuvant epirubicin and ifosfamide chemotherapy: a case report.

Frontiers in oncology·2026
Same author

Ultrasound-guided radiofrequency ablation for recurrent contralateral tumors that developed after initial surgery for papillary thyroid carcinoma.

Frontiers in endocrinology·2026
Same author

DCVBin: a novel binning method for single-sample metagenomes based on DNA language model and variational autoencoder.

Briefings in bioinformatics·2026

相关实验视频

Updated: May 30, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K

相互DTA:一种可解释的药物向亲和力预测模型,利用预先训练的模型和相互关注.

Yongna Yuan1, Siming Chen1, Rizhen Hu1

  • 1School of Information Science & Engineering, Lanzhou University, Lanzhou 730000, China.

Journal of chemical information and modeling
|January 29, 2025
PubMed
概括

这项研究介绍了MutualDTA,这是一个可解释的深度学习模型,用于药物向亲和力 (DTA) 预测. MutualDTA提高了DTA预测的准确性和可解释性,有助于对阿尔茨海默氏症等疾病的药物发现.

科学领域:

  • 计算化学是一种计算化学.
  • 药理学 药理学是指药理学的学科.
  • 人工智能在药物发现中的作用

背景情况:

  • 药物向亲和力 (DTA) 预测对于加速药物开发至关重要.
  • 现有的用于DTA预测的深度学习模型存在数据表示不足,特征提取不完整,缺乏可解释性等问题.
  • 解决这些局限性对于推进计算药物发现至关重要.

研究的目的:

  • 提出MutualDTA,一个可解释的深度学习模型,用于准确的DTA预测.
  • 增强数据表示和特征提取,以改进DTA建模.
  • 在药物标绑定预测中提供可解释性.

主要方法:

  • 使用预训练模型来准确地表示药物和目标.
  • 采用专门的模块来进行全面的隐藏特征提取.
  • 实施相互注意模块,用于建模分子间相互作用和识别结合点.

主要成果:

  • 在两个基准数据集上,MutualDTA的表现超过了12个最先进的模型.
  • 注意力可视化展示了MutualDTA识别部分交互点的能力,提高了可解释性.
  • 应用MutualDTA用于查与阿尔茨海默病相关的标,确定了潜在的候选药物.

更多相关视频

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.4K

相关实验视频

Last Updated: May 30, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.4K

结论:

  • MutualDTA为DTA预测提供了一种可靠和可解释的方法.
  • 该模型通过减少绑定网站的搜索空间来帮助药物开发商.
  • 互助DTA在加快对阿尔茨海默氏症等疾病有效候选药物的识别方面表现有前途.